ARK Invest

Superinvestor

ARK Investment Management LLC

SEC CIK: 0001697748
Manager: Cathie Wood
Style: Growth
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by ARK Invest, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 20; Since Q1 2021

Holdings of REGN by ARK Invest, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−110−100.0%	Sold out	Holders
Q4 2025	110	$84.7K	<0.1%	−12,032−99.1%	Reduced	Holders
Q3 2025	12,142	$6.83M	<0.1%	−464−3.7%	Reduced	Holders
Q2 2025	12,606	$6.62M	<0.1%	−1,088−7.9%	Reduced	Holders
Q1 2025	13,694	$8.69M	0.1%	+502+3.8%	Added	Holders
Q4 2024	13,192	$9.40M	0.1%	−1,959−12.9%	Reduced	Holders
Q3 2024	15,151	$15.9M	0.1%	−714−4.5%	Reduced	Holders
Q2 2024	15,865	$16.7M	0.1%	−2,348−12.9%	Reduced	Holders
Q1 2024	18,213	$17.5M	0.1%	−9,518−34.3%	Reduced	Holders
Q4 2023	27,731	$24.4M	0.1%	−90.0%	Reduced	Holders
Q3 2023	27,740	$22.8M	0.2%	−4,513−14.0%	Reduced	Holders
Q2 2023	32,253	$23.2M	0.2%	−1,338−4.0%	Reduced	Holders
Q1 2023	33,591	$27.6M	0.2%	−462−1.4%	Reduced	Holders
Q4 2022	34,053	$24.6M	0.2%	−2,888−7.8%	Reduced	Holders
Q3 2022	36,941	$25.4M	0.2%	−18,870−33.8%	Reduced	Holders
Q2 2022	55,811	$37.1M	0.2%	−1,962−3.4%	Reduced	Holders
Q1 2022	57,773	$40.4M	0.2%	−15,220−20.9%	Reduced	Holders
Q4 2021	72,993	$46.1M	0.1%	−355,154−83.0%	Reduced	Holders
Q3 2021	428,147	$259.1M	0.6%	−284,901−40.0%	Reduced	Holders
Q2 2021	713,048	$398.3M	0.7%	−505,922−41.5%	Reduced	Holders
Q1 2021	1,218,970	$576.7M	1.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.